Ekso Bionics Holdings Inc (NASDAQ: EKSO) on Tuesday, soared 4.30% from the previous trading day, before settling in for the closing price of $0.57. Within the past 52 weeks, EKSO’s price has moved between $0.47 and $2.16.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 11.70% over the past five years. The company achieved an average annual earnings per share of 54.55%. With a float of $21.09 million, this company’s outstanding shares have now reached $22.00 million.
Let’s look at the performance matrix of the company that is accounted for 70 employees. In terms of profitability, gross margin is 51.84%, operating margin of -66.05%, and the pretax margin is -62.95%.
Ekso Bionics Holdings Inc (EKSO) Insider and Institutional Ownership
Observing investor behavior towards Medical Instruments & Supplies industry stocks is more important than anything else. The insider ownership of Ekso Bionics Holdings Inc is 4.15%, while institutional ownership is 19.52%.
Ekso Bionics Holdings Inc (EKSO) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 54.55% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 55.80% during the next five years compared to 30.19% growth over the previous five years of trading.
Ekso Bionics Holdings Inc (NASDAQ: EKSO) Trading Performance Indicators
Ekso Bionics Holdings Inc (EKSO) is currently performing well based on its current performance indicators. A quick ratio of 2.14 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.74.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.65, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.23 in one year’s time.
Technical Analysis of Ekso Bionics Holdings Inc (EKSO)
Ekso Bionics Holdings Inc (NASDAQ: EKSO) saw its 5-day average volume 0.27 million, a negative change from its year-to-date volume of 2.06 million. As of the previous 9 days, the stock’s Stochastic %D was 73.74%. Additionally, its Average True Range was 0.06.
During the past 100 days, Ekso Bionics Holdings Inc’s (EKSO) raw stochastic average was set at 15.53%, which indicates a significant decrease from 77.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 69.70% in the past 14 days, which was lower than the 85.94% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6332, while its 200-day Moving Average is $0.9689. Nevertheless, the first resistance level for the watch stands at $0.6033 in the near term. At $0.6118, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.6233. If the price goes on to break the first support level at $0.5833, it is likely to go to the next support level at $0.5718. The third support level lies at $0.5633 if the price breaches the second support level.
Ekso Bionics Holdings Inc (NASDAQ: EKSO) Key Stats
Market capitalization of the company is 13.08 million based on 21,998K outstanding shares. Right now, sales total 18,280 K and income totals -15,200 K. The company made 4,130 K in profit during its latest quarter, and -2,070 K in sales during its previous quarter.
